美国青少年疑似代谢功能障碍相关脂肪性肝病的患病率及预测因素
基于2011至2020年美国国家健康与营养调查的横断面分析,纳入12-19岁青少年,以性别特异性丙氨酸氨基转移酶(ALT)上限定义升高。14.6%的青少年ALT升高,其中77.2%符合疑似MASLD标准。体重指数与ALT升高的关联最强(OR 3.55)。
要点
- 美国青少年中14.6%存在ALT升高,其中77.2%符合疑似MASLD标准。
- 体重指数与ALT升高的关联最强(OR 3.55),其次为高甘油三酯(OR 2.09)。
- 部分ALT升高青少年无心血管代谢危险因素,称为隐源性ALT升高(占20.2%)。
核心结论
- 大多数ALT升高的青少年符合MASLD标准,但部分缺乏心血管代谢危险因素或其他可识别病因。
- 结果支持在青少年中采用MASLD标准,同时提示需要对儿科人群中的隐源性ALT升高进行进一步研究。
研究设计与样本
- 研究为横断面分析,数据来自2011至2020年美国国家健康与营养调查,对象为12-19岁青少年。
- ALT升高定义为性别特异性生物学上限:男性>26 U/L,女性>22 U/L。
主要发现
- 总体14.6%的青少年存在ALT升高。
- 在ALT升高的青少年中,77.2%为疑似MASLD,20.2%为隐源性ALT升高,1.9%使用肝毒性药物,0.7%有病毒性肝炎。
- 体重指数与ALT升高的关联最强(OR 3.55),其次为高甘油三酯(OR 2.09)、低高密度脂蛋白胆固醇(OR 2.05)和高血压(OR 1.93)。
关键数值与推荐
- 疑似MASLD定义为ALT升高且至少存在一项心血管代谢危险因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nomenclature for steatotic liver disease has been updated to include metabolic dysfunction-associated steatotic liver disease (MASLD), which requires the presence of hepatic steatosis and at least one cardiometabolic risk factor. The prevalence of MASLD in adolescents is understudied. AIM: To determine the prevalence of suspected MASLD among adolescents in the United States and to examine the relationships between elevated alanine aminotransferase (ALT) and cardiometabolic risk factors. METHODS: A cross-sectional analysis of the National Health and Nutrition Examination Survey from 2011 to 2020 was conducted for adolescents aged 12-19 years. Elevated ALT was defined using sex-specific biological upper limits: > 26 U/L for males and > 22 U/L for females. Suspected MASLD was identified by elevated ALT and at least one cardiometabolic risk factor. Adolescents with elevated ALT were categorised as having suspected MASLD, elevated ALT due to other causes or cryptogenic ALT elevation. RESULTS: Overall, 14.6% of adolescents had elevated ALT. Of these, 77.2% had suspected MASLD, 20.2% had cryptogenic ALT elevation, 1.9% took hepatotoxic medications and 0.7% had viral hepatitis. Body mass index had the strongest association with elevated ALT (OR 3.55), followed by high triglycerides (OR 2.09), low HDL cholesterol (OR 2.05) and high blood pressure (OR 1.93). CONCLUSIONS: Most adolescents with elevated ALT met MASLD criteria, yet a portion lacked cardiometabolic risk factors or other identifiable causes. These results support the adoption of MASLD criteria in adolescents while indicating a need for further research into cryptogenic ALT elevation in paediatric populations.
引用
- Noon SL, Chun LF, Lam TBN, et al. Prevalence and Predictors of Suspected Metabolic Dysfunction-Associated Steatotic Liver Disease in Adolescents in the United States. Aliment Pharmacol Ther. 2025. PMID: 39943715. doi:10.1111/apt.70022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。